For research use only. Not for therapeutic Use.
PIT-1 is a selective PIP3 (phosphatidylinositol 3,4,5-trisphosphate) antagonist. PIT-1 inhibits cancer cell survival and induces apoptosis by inhibition of PIP3 dependent PI3K / Akt signaling. PIT-1 exhibits antitumor activity in vivo[1].
| Catalog Number | I010676 |
| CAS Number | 53501-41-0 |
| Synonyms | N-[(3-chloro-2-hydroxy-5-nitrophenyl)carbamothioyl]benzamide |
| Molecular Formula | C14H10ClN3O4S |
| Purity | ≥95% |
| InChI | InChI=1S/C14H10ClN3O4S/c15-10-6-9(18(21)22)7-11(12(10)19)16-14(23)17-13(20)8-4-2-1-3-5-8/h1-7,19H,(H2,16,17,20,23) |
| InChIKey | RIGXBXPAOGDDIG-UHFFFAOYSA-N |
| SMILES | C1=CC=C(C=C1)C(=O)NC(=S)NC2=C(C(=CC(=C2)[N+](=O)[O-])Cl)O |
| Reference | [1]. Miao B, et al. Small molecule inhibition of phosphatidylinositol-3,4,5-triphosphate (PIP3) binding to pleckstrin homology domains. Proc Natl Acad Sci U S A. 2010 Nov 16;107(46):20126-31. |
